Evidence map›Paper›PMID 40363672›Full record

ReviewMolecules (Basel, Switzerland)2025

Research Progress of Photothermal Superhydrophobic Surfaces for Anti-Icing/Deicing.

Hui Gao, Tianjun Yin, Jieyin Ma, Yuqin Zhou, Ke Li, Jiayi Bao

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hui GaoSchool of Aeronautic Science and Engineering, Beihang University, Beijing 100191, China.ORCID 0000-0003-1000-1632
Tianjun YinSchool of Aeronautic Science and Engineering, Beihang University, Beijing 100191, China.
Jieyin MaSchool of Aeronautic Science and Engineering, Beihang University, Beijing 100191, China.
Yuqin ZhouSchool of Aeronautic Science and Engineering, Beihang University, Beijing 100191, China.
Ke LiSchool of Aeronautic Science and Engineering, Beihang University, Beijing 100191, China.
Jiayi BaoSchool of Aeronautic Science and Engineering, Beihang University, Beijing 100191, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photothermal superhydrophobic surfaces with micro/nano-structured morphologies have emerged as promising candidates for anti-icing and deicing applications due to their exceptional water repellency and efficient solar-to-thermal conversion. These surfaces synergistically integrate the passive icephobicity of superhydrophobic coatings with the active heating capability of photothermal materials, offering energy-efficient and environmentally friendly solutions for sectors such as aviation, wind energy, and transportation. Hence, they have received widespread attention in recent years. This review provides a comprehensive overview of recent advances in photothermal superhydrophobic coatings, focusing on their anti-icing/deicing mechanisms, surface wettability, and photothermal conversion performance for anti-icing/deicing applications. Special emphasis is placed on material categories, including metals and their compounds, carbon-based materials, and polymers, analyzing their structural features and application effectiveness. Furthermore, the application of anti-icing/deicing in various fields is described. Finally, perspectives on future development are presented, including pursuing fluorine-free, cost-effective, and multifunctional coatings to meet the growing demand for innovative, sustainable anti-icing/deicing technologies.

Indexed as

advanced coatingsanti-icing/deicingapplicationsphotothermalsuperhydrophobic surfaces

Identifiers

PMID40363672
PMCPMC12073101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.